All Albumin Biomanufacturing Biosimilar policy Peptide VHH A new way to repurpose biological therapeutics Delivering high titre by harnessing the power of evolution New technology unlocks the bioprocessing economy Net titre is the true measure of bioprocessing productivity Ginkgo’s predicament calls for radical new approach How Does Synthetic Biology Work? Bringing the power of evolution to bioprocessing Could titre torpedo your biological therapeutic? New genomic technology promises affordable animal vaccines Could VHH become a serious threat to monoclonal antibodies? Can new technologies tackle the escalating cost of healthcare? Baker’s yeast to transform VHH discovery and manufacture Page 1 Page 2 ⟩
